Literature DB >> 9765319

Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide.

H Ishizuka1, K Konno, H Naganuma, K Nishimura, H Kouzuki, H Suzuki, B Stieger, P J Meier, Y Sugiyama.   

Abstract

The mechanism for hepatic uptake of temocaprilat, an angiotensin-converting enzyme inhibitor that is predominantly excreted into bile was studied using isolated rat hepatocytes and COS-7 cells expressing the organic anion transporting polypeptide (oatp1). The uptake of temocaprilat into isolated rat hepatocytes exhibited saturation with a Km of 20.9 microM and a Vmax of 0.21 nmol/min/mg protein. This uptake was temperature sensitive and was significantly reduced by metabolic inhibitors, a sulfhydryl-modifying reagent and an anion-exchange inhibitor, although the replacement of Na+ with Li+ in the medium did not affect the uptake. [3H]Temocaprilat uptake was inhibited by estradiol-17beta-D-glucuronide and dibromosulphophthalein, typical substrates for the Na+-independent organic anion transporter, in a concentration-dependent manner, whereas excess estradiol-17beta-D-glucuronide did not completely inhibit the uptake. Temocaprilat uptake into COS-7 cells transfected with oatp1 cDNA revealed a concentration-dependency with a Km of 46.7 microM, a value comparable with that obtained in isolated hepatocytes. The contribution of oatp1 to carrier-mediated hepatic uptake of temocaprilat was less than 50% by correcting the uptake clearance with that of estradiol-17beta-D-glucuronide. A good linear correlation was observed for the inhibitory effect of angiotensin-converting enzyme inhibitors (benazeprilat, cilazaprilat, delaprilat and enalaprilat) between isolated hepatocytes and oatp1-expressing cells. These data suggest that oatp1, along with another transporter(s), mediates the uptake of angiotensin-converting enzyme inhibitors into rat hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765319

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Different accumulation of temocapril and enalapril during repeated dosing in elderly patients.

Authors:  Masashi Arakawa; Masami Ohmori; Ken-ichi Harada; Nobutaka Araki; Tetsuo Saitoh; Akio Fujimura
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

2.  Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport.

Authors:  Yoshihisa Shitara; Daisuke Sugiyama; Hiroyuki Kusuhara; Yukio Kato; Takaaki Abe; Peter J Meier; Tomoo Itoh; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

3.  Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels.

Authors:  Thomas Gerloff; Melanie Schaefer; Jessica Mwinyi; Andreas Johne; Thomas Sudhop; Dieter Lütjohann; Ivar Roots; Klaus von Bergmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-28       Impact factor: 3.000

4.  Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X.

Authors:  B Hagenbuch; I D Adler; T E Schmid
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

Review 5.  Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution.

Authors:  Thomas Gerloff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-04       Impact factor: 3.000

6.  Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus.

Authors:  Hiroyuki Kusuhara; Zhonggui He; Yoshinori Nagata; Yoshitane Nozaki; Takashi Ito; Hiroyuki Masuda; Peter J Meier; Takaaki Abe; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

Review 7.  The SLCO (former SLC21) superfamily of transporters.

Authors:  Bruno Hagenbuch; Bruno Stieger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

Review 8.  How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion.

Authors:  Douglas B Kell; Stephen G Oliver
Journal:  Front Pharmacol       Date:  2014-10-31       Impact factor: 5.810

9.  Novel testing strategy for prediction of rat biliary excretion of intravenously administered estradiol-17β glucuronide.

Authors:  Annelies Noorlander; Eric Fabian; Bennard van Ravenzwaay; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2020-11-07       Impact factor: 5.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.